Introduction to the problem
===========================

Classic theories of molecular evolution of animals started from comparison of amino acid sequences of proteins and protein- or RNA-encoding DNA sequences. However, expanding knowledge of non-coding sequences in the genome, widely upstream, downstream or intragenic regions of various genes, owing to the whole genome sequencing of various animal species, indicated new and important aspects of the genomic basis of organismal evolution.

For successful derivation of a living organism from a fertilized egg through the developmental process, genes included in a genome must be regulated in precise spatio-temporal order. This regulation is accomplished by association to individual genes of many regulatory sequences, e.g. enhancers, to satisfy different spectra of regulations at individual stages and sites of embryonic development. However, in contrast to the coding sequences of the genome predictable from possession of long ORFs (open reading frames) or matching with ESTs (expressed sequence tags), the non-coding regulatory sequences are definable only by biological functional assays.

Genomic comparison of sequences of various vertebrate species has indicated the presence of many blocks of highly conserved non-coding sequences scattered around and between genes, and at least some of them have been shown to have regulatory functions acting as enhancers.^[@b1-pjab-85-55]--[@b5-pjab-85-55]^ This observation provided a new routine to investigate regulatory sequences: to find phylogenetically conserved sequences first, then examine these sequences by functional assays. However, not all regulatory sequences are conserved across a wide range of phyla and the range of conservation depends on individual enhancers.^[@b3-pjab-85-55],[@b6-pjab-85-55],[@b7-pjab-85-55]^

For embryonic development, regulatory functions attributed to a group of genes, which usually correspond to a set of paralogous genes generated through multiple rounds of genomic duplication, is more important than the activity of individual genes. The genomic duplication took place twice for many vertebrates and three times for teleosts, creating paralogous genes. The possible consequence of the creation of functionally analogous paralogue genes has been formulated in a model by Force *et al.*^[@b8-pjab-85-55]^ based on then available information; namely inactivation, subfunctionalization and neo-functionalization (gaining of new function by a paralogous gene with the original function being maintained by other paralogous genes). However, the correlation between variation of paralogous gene function and phylogenetical conservation has not been investigated in a systematic fashion. In fact, employment of paralogous genes in a particular developmental process varies considerably among animal species. As will be discussed in this article, regulatory sequences evolve dynamically within the framework of conservation of the overall regulatory function attributed to a paralogous gene set.

Our group has investigated the regulation of *Sox2* and its related (paralogous) genes belonging to group B1 *Sox* genes, for their involvement in the regulation of neural primordia at various developmental stages. The *Sox2* gene is regulated by an unexpectedly large number of distinct enhancers that are widely scattered in a genomic region centered around the gene. Analysis of interspecies conservation of these enhancer sequences and regulatory functions provide a global view of how *Sox2* enhancers evolved in coordination with variation in paralogue employment, fulfilling regulatory functions attributed to group B1 *Sox* genes. This article aims to synthesize two aspects of genomic evolution, variable employment of paralogous genes and the variable extent of phylogenetic conservation of regulatory sequences.

Involvement of many enhancers in *Sox2* gene regulation
=======================================================

The embryonic neural primordia, starting from neural plates and continuing to the ventricular zone of the neural tube express *Sox* genes belonging to group B1^[@b9-pjab-85-55]--[@b13-pjab-85-55]^ (Okuda *et al.*, unpublished results). Neural primordial states are sustained by the shared functions of group B1 *Sox* genes.^[@b14-pjab-85-55],[@b15-pjab-85-55]^ Group B1 *Sox* genes encode transcription factors with identical DNA binding specificity and very similar transactivation potentials,^[@b16-pjab-85-55]--[@b19-pjab-85-55]^ but differ in the expression pattern in both spatial and temporal aspects, although their expression overlaps extensively in the neural primordia. In higher vertebrates represented by amniotes, three *Sox* genes, *Sox1*, *Sox2* and *Sox3*, comprise group B1, among which *Sox2* dominates over the other two in the expression domains, as well as in regulatory functions. Expression of *Sox2* is coordinated with gastrulation events involving neural induction.^[@b20-pjab-85-55]^ It covers the entire domain of neural primordium,^[@b9-pjab-85-55]--[@b13-pjab-85-55],[@b21-pjab-85-55]^ and continues to neural stem cells of later stages.^[@b22-pjab-85-55]^ For these reasons, expression of the transcription factor gene *Sox2* is considered a "panneural" marker in higher vertebrates. Functionally, the impact of knockout of individual group B1 *Sox* genes is distinct between *Sox2* and the other two *Sox* genes. Homozygous knockout mice for *Sox1* and *Sox3* are somehow viable with minor neuro-sensory^[@b23-pjab-85-55]--[@b25-pjab-85-55]^ or neuro-endocrinal defects,^[@b26-pjab-85-55]^ respectively, whereas downregulation of *Sox2* alone in a CNS cell population causes a serious neurogenetic disorder.^[@b27-pjab-85-55]^ Thus, in higher vertebrates, *Sox2* expression and function prevail over other group B1 *Sox* genes.

Shown in [Fig. 1](#f1-pjab-85-55){ref-type="fig"} is the expression pattern of *Sox2* at various developmental stages for chicken embryo. At stage 4 when the organizer (Hensen's node) is formed, *Sox2* is activated in the organizer-surrounding region of epiblastic upper cell layer, and as the organizer moves posteriorly with development, new *Sox2*-expressing domains are posteriorly added in a continuous fashion. The initial domain of *Sox2* expression continues to express the gene, becomes anterior neural plate and forms the cephalic part of CNS, namely brain, while the posteriorly added *Sox2* expression domain mainly forms the spinal cord. After stage 10 of chicken embryogenesis, placodal precursors also express *Sox2. Sox2* expression thus marks neural and sensory primordia in embryos.

![Expression of *Sox2* in chicken embryo at various developmental stages marking neural and sensory primordia, as indicated by *in situ* hybridization. Anterior is toward the top. Photographs were taken at the same scale. The position of organizer (Hensen's node) is indicated by an arrowhead. Head ectoderm (E), lens placode (L) and otic vesicle (O) are indicated by arrows. Adapted from [Fig. 1A](#f1-pjab-85-55){ref-type="fig"} in Uchikawa *et al.* (2003). Functional analysis of chicken *Sox2* enhancers highlights an array of diverse regulatory elements that are conserved in mammals. Dev. Cell **4**, 509--519, with permission from Elsevier.](pjab-85-055-g001){#f1-pjab-85-55}

Although the expression of *Sox2* is thus continuous and persistent in time and space, we felt it unlikely that neural and sensory *Sox2* expression depends on simple regulatory mechanisms, considering the dynamic change in tissue environment for neuro-sensory primordia across the embryo axis and during developmental progression. Therefore, many regulatory sequences must be involved in *Sox2* gene regulation.

The experimental design we adopted took advantage of chicken embryo electroporation,^[@b4-pjab-85-55],[@b28-pjab-85-55]^ a technique initiated by Tatsuo Muramatsu and others^[@b29-pjab-85-55]^ and refined by the group of Harukazu Nakamura.^[@b30-pjab-85-55]^ It was at a time before whole genome sequences were available. We cloned and determined the DNA sequence of the 50-kb chicken genomic region encompassing the *Sox2* gene. We also constructed tk-EGFP vector to be used for chicken embryo electroporation.^[@b3-pjab-85-55]^ The advantage of this vector was that it would not express the fluorescent protein EGFP to any significant level unless an enhancer sequence was inserted. After insertion of an enhancer element, the vector activated EGFP expression sharply responding to the specificity and strength of the enhancer. Thus, we prepared a number of subgenomic fragments of the *Sox2*-surrounding region, inserted each in the tk-EGFP vector, and electroporated stage 4 embryo with these constructs on the epiblastic side or in stage 10 spinal cord, in order to examine if any enhancer activity is borne by the inserted DNA sequence. Once an enhancer activity was found to be associated with the inserted DNA, its subfragments were reexamined for enhancer activity using the same technique. By repeating this procedure, eleven different enhancers were identified in the 50 kb *Sox2* genomic sequence ([Fig. 2](#f2-pjab-85-55){ref-type="fig"}).^[@b3-pjab-85-55]^ Boundaries of the enhancers were roughly determined as the limits where smaller subfragments showed a decrease in enhancer activity. Five of the enhancers, N-1 to N-5, were active in the embryonic CNS ([Fig. 3A](#f3-pjab-85-55){ref-type="fig"}).

![Determination of *Sox2* enhancers with activities in various and distinct domains of embryonic CNS and sensory placodes. Genomic fragments covering the 50 kb region of chicken *Sox2* locus were individually tested for enhancer activity in electroporated chicken embryos. DNA fragments that demonstrated an enhancer activity are shown in red, and functionally determined enhancers are indicated by boxes on the map (middle). Adapted from [Fig. 2](#f2-pjab-85-55){ref-type="fig"} in Uchikawa *et al.* (2003). Functional analysis of chicken *Sox2* enhancers highlights an array of diverse regulatory elements that are conserved in mammals. Dev. Cell **4**, 509--519, with permission from Elsevier.](pjab-85-055-g002){#f2-pjab-85-55}

![Conserved activity of enhancers N-1 to N-5 between chicken and mouse. (A) Domains of the embryonic CNS where chicken enhancers N-1 to N-5 show activity in electroporated embryo compared to *Sox2* expression (*in situ* hybridization) of stage 11 embryo. Fluorescence images (green) representing enhancer activities are overlaid on darkened bright-field images to indicate respective embryonic domains. "r" indicates the rhombencephalic domain. The orange speckles in the enhancer N-5 specimen are due to DsRed fluorescence that was derived from co-electroporated control vector and not removed completely by optical filtration. (B) Alignment of chicken and mouse *Sox2* enhancers with nucleotide sequence identity expressed as a percentage. (C) Activity of mouse enhancers at E9--9.5 in transgenic mouse embryos, compared to *Sox2 in situ* hybridization. Transgenes for *Sox2* enhancers, except for enhancer N-1, were constructed by introducing each tetrameric *Sox2* enhancer of mouse upstream of the *hsp68* promoter-*LacZ* cassette,^[@b44-pjab-85-55]^ and primary transgenic embryos were examined. Tetrameric N-1 enhancer in a *tk-LacZ* vector was used to generate transgenic lines.](pjab-85-055-g003){#f3-pjab-85-55}

Enhancer N-1 was active in the embryonic domain surrounding the organizer, and the domain moved posteriorly together with the organizer. Enhancer N-2 was active in the wide anterior domain of the CNS and covered most of the future brain. Enhancer N-3 was active in the diencephalon, optic vesicle (future retina) and mesencephalon. Enhancer N-4 showed its activity posterior to the mesencephalon with a gap of activity in the rhombencephalic region, with the activity of enhancer N-5 in the rhombencephalic region filling this gap. Thus, by combining the activity of all these enhancers, original *Sox2* expression patterns earlier than stage 12 were reconstructed ([Fig. 3A](#f3-pjab-85-55){ref-type="fig"}), indicating that enhancers N-1 to N-5 fully account for the regulation of *Sox2* in these early developmental stages.

Electroporation of spinal cord of later stage embryo allowed identification of SC-1 and SC-2, enhancers active in the spinal cord and NC-1 active in dorsal spinal cord-derived neural crest cells ([Fig. 2](#f2-pjab-85-55){ref-type="fig"}).

Enhancer N-4 was also active in the cephalic ectoderm that derivates sensory placodes, and enhancer N-3 showed activity in the lens placode. In addition, three enhancers showed activity in the developing sensory systems: NOP-1 and NOP-2 in the nasal and otic placodes, and enhancer L in the lens fibers ([Fig. 2](#f2-pjab-85-55){ref-type="fig"}).

Correspondence of functionally defined enhancers with phylogenetically conserved sequence blocks
================================================================================================

Comparison of the *Sox2* locus sequence of the chicken with those of human and mouse indicated the following interesting points ([Fig. 4A](#f4-pjab-85-55){ref-type="fig"}).^[@b3-pjab-85-55]^ (1) Twenty-five highly conserved sequence blocks were clearly recognized (Three of the blocks are not conserved in the mouse sequence, but this represents a unique situation for the mouse). (2) Ten of the functionally defined enhancers matched very well to those of conserved sequence blocks. (Enhancer L is missing in the mammalian sequences, consistent with the lack of *Sox2* expression in mammalian lens fibers, as will be discussed below) ([Fig. 4A](#f4-pjab-85-55){ref-type="fig"}). (3) The correspondence between the functionally defined enhancers and conserved blocks of sequences were clear when chicken and mammalian sequences were compared, however the enhancer sequences were completely embedded in much longer stretches of non-functional sequence conservation when two mammalian genomes were compared ([Fig. 4B](#f4-pjab-85-55){ref-type="fig"}). These observations indicated that the phylogenetic distance between birds and mammals is just appropriate for predicting functionally significant sequences, such as enhancers, as highly conserved non-coding sequences.

![Correspondence of the functionally defined *Sox2* enhancers with blocks of highly conserved sequences found by comparison of chicken and mammalian *Sox2* locus sequences. (A) Conserved sequence blocks found in the *Sox2* locus sequences of amniotes. Blocks of sequences that show \> 60% identity over the stretch of 100 base pairs are indicated by boxes. The 25 sequence blocks No. 1 to No. 25 conserved between chicken and mammalian sequences are indicated on the top. Blocks No. 3, 21 and 25 marked by asterisks are not conserved in the mouse sequence. Sequences conserved between human and mouse genomic sequences but not strongly conserved in the chicken sequence are indicated in blue. (B) Dot matrices comparing DNA sequences of the three animal sequences encompassing enhancer N-5 (conserved sequence block No. 14). A dot indicates a 10 bp sequence with \> 60% matching. Between the chicken and mammalian sequences, only the enhancer sequence is significantly conserved, however between human and mouse, the enhancer sequence is embedded in a broader region of possibly non-functional sequence conservation. Adapted from [Fig. 6](#f6-pjab-85-55){ref-type="fig"} in Uchikawa *et al.* (2003). Functional analysis of chicken Sox2 enhancers highlights an array of diversity regulatory elements that are conserved in mammals. Dev. Cell **4**, 509--519, with permission from Elsevier.](pjab-85-055-g004){#f4-pjab-85-55}

The early neural enhancers N-1 to N-5 of *Sox2* were conserved well in the mouse not only in the DNA sequence, but also in their regulatory functions ([Fig. 3B, C](#f3-pjab-85-55){ref-type="fig"}). The mouse versions of enhancers N-1 to N-5 were regulated similar to chicken counterparts in electroporated chicken embryos, and in transgenic mouse embryos where the *lacZ* gene was expressed under the regulation of the mouse version of *Sox2* enhancers ([Fig. 3C](#f3-pjab-85-55){ref-type="fig"}).

Distinct regulation of enhancers N-2 and N-1 governing development of anterior and posterior neural plates
==========================================================================================================

It is not that all enhancers N-1 to N-5 are activated simultaneously, but that enhancers N-1 and N-2 are activated first, followed by the addition of activities of N-3, N-4 and N-5 in this sequence.^[@b3-pjab-85-55]^ Thus, when the developmental stages are taken much earlier than those shown in [Fig. 3](#f3-pjab-85-55){ref-type="fig"}, the active *Sox2* enhancers are only N-1 and N-2. As indicated by two-color fluorescence representing the unover-lapping activities of enhancer N-1 (red) and N-2 (green) in electroporated chicken embryo ([Fig. 5A](#f5-pjab-85-55){ref-type="fig"}), the future brain and future spinal cord portions of the CNS are already distinct at this stage. Regulation of these enhancers has been studied in great detail^[@b31-pjab-85-55]^ (Iwafuchi *et al.*, unpublished). Enhancer N-1 is actually active in the primordial cell population called the "stem zone" located in the anterior-most domain of the primitive streak, which serves itself as the common precursor for posterior neural plate and paraxial mesoderm.^[@b32-pjab-85-55],[@b33-pjab-85-55]^ As summarized in [Fig. 5B](#f5-pjab-85-55){ref-type="fig"}, enhancer N-1 is activated by the combined action of Wnt and FGF signals and repressed when the stem zone cells are positioned in the mesodermal lineage, possibly by the action of T-box factors, through respective target regulatory sites present in the N-1 core sequence.^[@b31-pjab-85-55]^ Enhancer N-2 is not affected by any of these signals or factors, confirming independent regulation of anterior and posterior neural plates.

![Distinct characteristics of enhancers N-2 and N-1 that regulate *Sox2* in anterior and posterior neural plates, respectively. A. In early stage chicken embryos, N-2 and N-1 are the only active *Sox2* enhancers, covering un-overlapping anterior (N-2, red fluorescence of mRFP1) and posterior domains (N-1, green fluorescence of EGFP) of the developing CNS. B. Regulatory modules of enhancer N-1 core sequence determined by Takemoto *et al.*^[@b31-pjab-85-55]^ C. When a tk-mCherry vector carrying chicken enhancer N-2 was injected into zebrafish embryo, it was regulated to have activity in the anterior neural plate, whereas analogous tk-Venus vector carrying dimeric chicken N-1 was not activated with regional restriction.](pjab-85-055-g005){#f5-pjab-85-55}

Difference in the range of cross-species conservation between enhancers N-2 and N-1
===================================================================================

Given that the regulation of anterior and posterior neural plates are distinct, as exemplified by the independence of enhancers N-2 and N-1, it is interesting to learn how these regulations are conserved across phyla. Recent extension of whole genome sequencing to various vertebrate species opened up a new perspective concerning this issue.

The sequence of enhancer N-2, in particular the essential core region (Iwafuchi *et al.*, unpublished), is strongly conserved through mammals, chicken, *Xenopus* to fish (zebrafish, tetraodon, medaka), as shown in [Fig. 6A](#f6-pjab-85-55){ref-type="fig"}. This holds true for other neural enhancers N-3,^[@b34-pjab-85-55]^ N-4 and N-5 showing activities in the anterior neural plate. Indeed, when tk-mCherry vector carrying the chicken N-2 enhancer sequence was injected into fertilized zebrafish egg, this vector was activated in the anterior neural plate of zebra-fish embryo ([Fig. 5C](#f5-pjab-85-55){ref-type="fig"}, top), demonstrating conservation of the overall regulatory system involved in the anterior neural plate *Sox2* expression.

![Differential range of phylogenetic conservation of *Sox2* enhancers. A. Comparison of highly conserved sequence blocks (boxes) and enhancers functionally assessed in higher vertebrates (colored boxes) among six animal species, human, mouse, opossum, chicken, *Xenopus* and zebrafish. Enhancers showing activity in the brain-forming anterior CNS are connected by red lines, while those in the posterior CNS are connected by blue lines. Most of the enhancers showing activity in the posterior CNS are conserved in amniotes, however conservation is limited in *Xenopus* and absent in fish. B. Alignment of enhancer N-1 sequences between five animal species. Although the entire sequence is highly conserved among amniotes, sequence conservation is limited to the core-proximal sequences in *Xenopus*; even in the core sequence only one Lef1 binding sequence among three essential functional elements^[@b31-pjab-85-55]^ is conserved in the *Xenopus* sequence.](pjab-85-055-g006){#f6-pjab-85-55}

The situation for enhancer N-1 is very different. Although the entire enhancer N-1 sequence is strongly conserved within amniotes ([Fig. 6B](#f6-pjab-85-55){ref-type="fig"}, for human, mouse, opossum and chicken), sequence conservation is only partial in *Xenopus*, and is not found in any fish species. In the core sequence of 56 bp,^[@b31-pjab-85-55]^ the genetic elements for the activation of this enhancer, two Lef1 binding sites and an FGF signal-responsive sequence, are perfectly conserved among amniote species, however only one Lef1 site is conserved in *Xenopus* ([Fig. 6B](#f6-pjab-85-55){ref-type="fig"}).

When chicken enhancer N-1-bearing expression vector (tk-Venus) was injected into zebrafish eggs, the vector was expressed very weakly throughout the embryo possibly in response to FGF and Wnt signals, but without much posterior prominence ([Fig. 5C](#f5-pjab-85-55){ref-type="fig"}, bottom). This observation indicates that zebrafish embryos are not furnished with a defined system for posterior activation of enhancer N-1, in addition to lacking the N-1 sequence in the *Sox2* genomic region.

Minor position of *Sox2* among group B1 *Sox* genes in fish
===========================================================

Although *Sox2* plays the role of major "pan-neural" *Sox* gene in amniotes, it is a minor player and bears an anterior CNS-limited function among group B1 *Sox* genes in fish species. In contrast to higher vertebrates having three group B1 *Sox* genes, fish species, which have undergone an extra round of genome duplication, have six group B1 *Sox* genes, *Sox1a*, *Sox1b*, *Sox2*, *Sox3*, *Sox19a* and *Sox19b*. Of these, *Sox2*, *Sox3*, *Sox19a* and *Sox19b* are expressed during early embryonic stages, as shown in [Fig. 7A](#f7-pjab-85-55){ref-type="fig"}. In zebrafish, expression of *Sox2* is preceded by *Sox3*, *Sox19a* and *Sox19b*, and from the expression pattern, the "pan neural *Sox*" role is undertaken by *Sox19a* rather than *Sox2* ([Fig. 7B](#f7-pjab-85-55){ref-type="fig"}). Expression of *Sox2* is limited to the anterior neural plate and its derivatives, which are accounted for by activity of the conserved enhancer N-2 ([Fig. 7B](#f7-pjab-85-55){ref-type="fig"}).

![Expression of group B1 *Sox* genes in early stage zebrafish embryos. A. RT-PCR analysis of transcripts of *Sox1a*, *Sox1b*, *Sox2*, *Sox3*, *Sox19a* and *Sox19b* in embryos at various stages. *β*-*actin* was used as control for the reaction. B. Expression pattern of the genes at various developmental stages indicated by *in situ* hybridization (blue). Hybridization with *no tail* probe (orange) was used to mark mesodermal precursors in gastrulating embryos. Developmental fates of early embryonic stages are illustrated for comparison: NNE, non-neural ectoderm; NE, neural ectoderm; D, dorsal; V, ventral; F, forebrain; M, midbrain; H, hindbrain; SC, spinal cord. Arrowheads indicate the site of shield. In 12-somite stage embryos, optic vesicle (ov), otic placode (otp), fore-midbrain boundary (fmb) and mid-hindbrain boundary (mhb) are indicated. Reprinted from [Figs. 3](#f3-pjab-85-55){ref-type="fig"}, [4](#f4-pjab-85-55){ref-type="fig"} and [6A](#f6-pjab-85-55){ref-type="fig"} in Okuda *et al.* (2006). Comparative genomic and expression analysis of group B1 *sox* genes in zebrafish indicates their diversification during vertebrate evolution. Dev. Dyn. **235**, 811--825, with permission from Wiley-Blackwell.](pjab-85-055-g007){#f7-pjab-85-55}

*Sox2* is not expressed to a significant level in the spinal cord of zebrafish embryos ([Fig. 7B](#f7-pjab-85-55){ref-type="fig"}). This is likely a reflection of the lack of conservation of enhancer N-1 sequence and some other spinal cord-related enhancers of *Sox2*, SC-2 and NC-1, in the fish genome ([Fig. 6A](#f6-pjab-85-55){ref-type="fig"}).

Evolution of group B1 *Sox* genes
=================================

The above observations may be retrospectively summarized as "enhancer N-1 and spinal cord related regulations of *Sox2* are not conserved in lower vertebrates", but considering the sequence of events underlying genomic evaluation, the actual situation may be that *Sox2* gradually gained its dominance among group B1 *Sox* genes by acquiring additional regulatory sequences for expression of *Sox2* in the posterior CNS. As the set of enhancers for vertebrate group B *Sox* prototype genes ([Fig. 8](#f8-pjab-85-55){ref-type="fig"}, below) is not known, it is difficult to distinguish whether a particular enhancer is really acquired through the evolutionary process or has remained 'unlost'. Nevertheless, enhancer acquiring should be considered an important process for evolution of genome function.

![Evolutionary history of genesis of group B1 *Sox* paralogues as a consequence of multiple rounds of genomic duplication. "Vertebrate group B *Sox* prototypic composition" is hypothetical. Linkages of "*Sox14* and *Sox2*" and "*Sox21* and *Sox1*" are conserved in human and other primates, cow and chicken, but disrupted in mouse after extensive chromosomal rearrangements (Ensembl 50, July 2008; <http://www.ensembl.org/index.html>).^[@b35-pjab-85-55]^ Linkage of "*Sox21* and *Sox1*" is found in a broader range of vertebrate species, e.g., dog, opossum, and medaka and other fish species, although this is disrupted in zebrafish. Linkages of "*Sox14* and *Sox2*" is reported for platypus.^[@b45-pjab-85-55]^ Linkages of these genes in *Xenopus* genome have not been confirmed.](pjab-85-055-g008){#f8-pjab-85-55}

To gain insight into this issue, evolution of the all paralogous group B1 *Sox* genes needs to be considered. Group B1 *Sox* genes code for transcriptional activators that act on group B1 SOX-specific target elements, such as *δ*-*crystallin* DC5 enhancer or *Nestin* core Nes30 enhancer.^[@b17-pjab-85-55],[@b18-pjab-85-55]^ Based on various criteria, group B1 SOX proteins have equivalent activities once expressed (Okuda *et al.*, unpublished results). Group B1 *Sox* genes have their relatives *Sox14* and *Sox21*, classified as group B2 *Sox* genes, the protein products of which bind to the same target sites as group B1 SOX proteins but repress gene transcription.^[@b11-pjab-85-55]^

As illustrated in [Fig. 8](#f8-pjab-85-55){ref-type="fig"}, a pair of prototypic B1 and B2 class *Sox* genes appears to have arisen by tandem duplication of a genomic locus, as (1) *Sox14-Sox2* and *Sox21-Sox1* pairs are conserved, including their local synteny in the chicken^[@b35-pjab-85-55]^ and human genomes,^[@b19-pjab-85-55]^ with the *Sox21-Sox1* linkage observed in wider vertebrate species (see legend to [Fig. 8](#f8-pjab-85-55){ref-type="fig"}), and (2) at least a pair of group B1 and group B2 *Sox* genes are recognizable in the genomes of lower animals, sponge,^[@b36-pjab-85-55]^ sea urchin,^[@b37-pjab-85-55]^ ascidian^[@b38-pjab-85-55]^ and amphioxus,^[@b39-pjab-85-55]^ although their linkages have not been confirmed.

Subsequently, two rounds of genomic duplication occurred, during which two group B2 *Sox* genes appear to have been lost, and the prototype of the vertebrate group \[B1 + B2\] *Sox* gene set must have been established (comprising the *Sox14-Sox2* pair, *Sox21-Sox1* pair plus *Sox3* and *Sox19*). The *Sox19*-type genes are characterized by their possession of an intron at a conserved position in the coding sequence, as in *Sox19a* and *Sox19b* in fish, in contrast to other intron-less group B1/B2 *Sox* genes.

As mentioned above, higher vertebrates have only three genes of group B1 *Sox*, *Sox1*, *Sox2* and *Sox3*. Thus, the evolutionary fate of *Sox19* in higher vertebrates has been an intriguing problem. An analysis of conserved synteny among animal species clearly indicates that the *Sox15* gene, found only in mammals and classified into the singleton G group, is derived from *Sox19. Sox15* indeed has an intron sequence in the same position as fish *Sox19a/b*. The genomic segment of zebrafish chromosome 5 encompassing the *Sox19a* gene, the zebrafish chromosome 7 segment including *Sox19b*, and the human chromosome 17 segment including *Sox15* are highly syntenic to one another. Despite this evolutionary history of its derivation, *Sox15*-encoded protein lacks the activity as a group B1 SOX protein, as assessed by activation of DC5 or Nes30 target sequences.^[@b19-pjab-85-55]^ Therefore, the derivation of *Sox15* in higher vertebrates from *Sox19* represents an example of "neofunctionalization"^[@b8-pjab-85-55]^ of a paralogous gene.

In *Xenopus*, the composition of group B1 *Sox* genes appears to reflect the vertebrate prototype, where *SoxD* reported by Yoshiki Sasai's group^[@b40-pjab-85-55]^ corresponds to *Xenopus Sox19*. The *SoxD* sequence is slightly more divergent compared to other group B1 *Sox* genes, but its expression in the neural primordia is typical of group B1 *Sox* genes ([Fig. 9B](#f9-pjab-85-55){ref-type="fig"}, below).

![Evolutionary shift of the major "pan-neural" group B1 *Sox* genes and of posterior coverage of the CNS by *Sox2*, *Sox3* and *Sox19* paralogues, as indicated by expression patterns in embryos at comparable developmental stages. (A) Expression pattern in zebrafish embryo of 3 somite stage. *Sox19a* is the most prevalent, while strong *Sox2* expression is mostly confined to the anterior CNS, as in other stages ([Fig. 7](#f7-pjab-85-55){ref-type="fig"}). Reprinted from [Fig. 5B](#f5-pjab-85-55){ref-type="fig"} in Okuda *et al.* (2006). Comparative genomic and expression analysis of group B1 *sox* genes in zebrafish indicates their diversification during vertebrate evolution. Dev. Dyn. **235**, 811--825, with permission from Wiley-Blackwell. Reported *Sox3* expression pattern in medaka embryo is analogous to zebrafish.^[@b46-pjab-85-55]^ (B) Expression pattern in *Xenopus* embryos at stage 13 and later, where *Sox3* is the major *Sox* gene expressed. Expression patterns of *Sox2* and *Sox3* are reproduced from [Fig. 1](#f1-pjab-85-55){ref-type="fig"} of Schlosser and Ahrens (2004). Molecular anatomy of placode development in *Xenopus laevis*. Dev. Biol. **271**, 439--466, and that of *SoxD* is reproduced from [Fig. 2](#f2-pjab-85-55){ref-type="fig"} of Mizuseki *et al.* (1998). SoxD: an essential mediator of induction of anterior neural tissues in *Xenopus* embryos. Neuron **21**, 77--85, with permission from the authors and Elsevier. (C) Expression pattern in chicken embryo at stage 8, where *Sox2* expression is dominating. In the chicken, *Sox19*-paralogous gene has not been identified. Arrows indicate the shift of major group B1 *Sox* among the species. A and P indicate anterior and posterior, respectively.](pjab-85-055-g009){#f9-pjab-85-55}

Evolutionary change of regulatory dominance and regional expression specificity among group B1 *Sox* genes
==========================================================================================================

Comparison of the expression patterns of representative group B1 *Sox* genes in the embryos of zebrafish, *Xenopus* and chicken ([Fig. 9](#f9-pjab-85-55){ref-type="fig"}) indicates a dramatic alteration of the dominating *Sox* gene among the B1 group during the evolutionary process. In zebrafish embryo, *Sox19* is the most prevailing in expression level and regional coverage, and *Sox2* is active only in the anterior CNS ([Fig. 9A](#f9-pjab-85-55){ref-type="fig"}).^[@b19-pjab-85-55]^ In *Xenopus* embryo, however, expression of *Sox3* appears to be dominating,^[@b41-pjab-85-55]^ while strong expression of *Sox19*-derived *SoxD* is confined to the anterior neural plate, although weak expression continues to the posterior neural plate.^[@b40-pjab-85-55]^ Very interestingly, in *Xenopus*, *Sox2* expression extends to the posterior neural plates, in good correspondence with possession of enhancer N-1 like sequence ([Fig. 6B](#f6-pjab-85-55){ref-type="fig"}). In embryos of chicken and other amniotes, the *Sox19* activity is lost, and *Sox2* expression prevails over the entire neural plate ([Fig. 9C](#f9-pjab-85-55){ref-type="fig"}).

This variation of the major *Sox* genes on service is not limited to the CNS. While activation of group B1 *Sox* genes is essential for lens development,^[@b17-pjab-85-55],[@b23-pjab-85-55],[@b42-pjab-85-55]^ employment of group B1 *Sox* genes for lens development is highly variable among vertebrate species. In the mouse embryo only *Sox1* is expressed in lens fibers,^[@b23-pjab-85-55],[@b43-pjab-85-55]^ but chicken embryonic lens has expression of *Sox1*, *Sox2* and *Sox3* in the fibers.^[@b43-pjab-85-55]^*Xenopus* embryo lens fibers express *Sox2* and *Sox3*,^[@b41-pjab-85-55]^ and lens fibers of zebrafish embryo express *Sox1a*, *Sox1b* and *Sox3*.^[@b19-pjab-85-55]^ This variation of group B1 *Sox* expression must reflect the variation of enhancers associated with individual *Sox* genes. In fact, lens fiber enhancer L of *Sox2* is conserved only between chicken and *Xenopus* ([Fig. 6A](#f6-pjab-85-55){ref-type="fig"}). This kind of variation in the paralogous gene employment between different animal species must occur in a vast variety of organogenic processes.

The phylogenetic change of the expression pattern of *Sox2* will largely be explained by the evolutionary gain of new enhancers or enhancer loss, as indicated in [Fig. 6A](#f6-pjab-85-55){ref-type="fig"}. Other group B1 *Sox* genes must have gone through analogous gain and/ or loss of regulatory sequences to generate each species-specific expression pattern of individual genes. An important point however, is that regardless of a gain or loss of the expression domain of individual *Sox* genes in a given species, overall balance of the activity of the group B1 SOX proteins appears to be conserved.

It is very often assumed that signaling systems to generate an organ rudiment in an embryo are conserved across wide vertebrate species without experimental verification. However, this is not a correct concept, according to the arguments and experience elaborated in this article. In the regulation of posterior neural plate development, signaling systems for posterior extension of *Sox19a* expression in zebrafish and that of *Sox2* (activating enhancer N-1) are likely different. Involvement of variable combinations of paralogous genes under distinct signaling systems in a defined organogenic process must always be considered when comparing results from different animal species.

This article summarizes our team effort over several years. We thank Drs. Gerhard Schlosser and Yoshiki Sasai for their provision of *Xenopus* data, and members of the Kondoh Laboratory for stimulating discussions. This study was supported by Grants-in-Aid for Scientific Research 18017019 and 18570197 to YK and 17107005 to HK. MI is a recipient of a fellowship from the Japan Society for the Promotion of Sciences for Japanese Junior Scientists.

Hisato Kondoh was born in 1949, and received his B.Sc. and Ph.D. from Kyoto University, Japan. He then served as Postdoctoral Fellow in the Department of Biochemistry, University of Wisconsin-Madison, USA. He returned to Kyoto University to take up the position of Assistant Professor in 1978 in the Department of Biophysics, when he started investigation of developmental gene regulation. He moved on to assume Professorships at Nagoya University Department of Molecular Biology (1988--1993) and Osaka University Institute for Molecular and Cellular Biology (1993--2003). He served as the Director of the Institute during 1999--2003. He is currently Professor at Osaka University Graduate School of Frontier Biosciences and also served as the Dean of the same institution from 2006--2008. To promote molecular studies in developmental biology and related areas, he organized several research projects and assumed the leadership, including those of Human Frontier Science Programs (1993--1996), Exploratory Research for Advanced Technology (1998--2004, Japan Science and Technology Agency), and Specially Promoted Research (COE) (2000--2005, MEXT Japan).

[^1]: (Communicated by Takao S[ekiya]{.smallcaps}, [m.j.a]{.smallcaps}.)
